Author

K. Cuppens

Institution: Jessa Hospital

Observed institution: Jessa Hospital

OpenAlex ID: A5017257261

21P: Primary analysis of safety, efficacy and immunogenicity of the therapeutic cancer vaccine PDC*lung01 with or without pembrolizumab in NSCLC: A multicenter phase I/II study

2025 · J.F. Vansteenkiste, I. Demedts, et al. · Journal of Thoracic Oncology

202P The therapeutic cancer vaccine PDC*lung01 induces immune responses with or without anti-PD-1 treatment in patients with non-small cell lung cancer

2022 · A. Sibille, J. Plumas, et al. · Immuno-Oncology Technology

Works count: 2

Citation count:

H-index:

I10-index: